PW02-040 - Low-penetrance NLRP3 variants

per Endres, T, Hofer, F, Goldbach-Mansky, R, Hoffman, HM, Blank, N, Krause, K, Rietschel, C, Horneff, G, Lohse, P, Kuemmerle-Deschner, J
Publicat 2013

PReS-FINAL-2331: Low-penetrance NLRP3 variants

per Endres, T, Hofer, F, Goldbach-Mansky, R, Hoffman, HM, Blank, N, Krause, K, Rietschel, C, Horneff, G, Lohse, P, Kuemmerle-Deschner, J
Publicat 2013

PW02-041 - Canakinumab treatment regimens in CAPS-patients

per Hofer, F, Endres, T, Kortus-Götze, B, Blank, N, Weißbarth-Riedel, E, Schuetz, C, Kallinich, T, Krause, K, Rietschel, C, Horneff, G, Kuemmerle-Deschner, J
Publicat 2013

PReS-FINAL-2224: Canakinumab treatment regimens in CAPS-patients

per Hofer, F, Endres, T, Kortus-Götze, B, Blank, N, Weißbarth-Riedel, E, Schütz, C, Kallinich, T, Krause, K, Rietschel, C, Horneff, G, Kuemmerle-Deschner, J
Publicat 2013

Canakinumab treat-to target strategies increase complete response rate in CAPS

per Kuemmerle-Deschner, J, Hofer, F, Endres, T, Kortus-Goetze, B, Blank, N, Weißbarth-Riedel, E, Schuetz, C, Kallinich, T, Krause, K, Rietschel, C, Horneff, G, Benseler, SM
Publicat a Pediatr Rheumatol Online J (2015)

P01-008 – FMF genotype-phenotype correlations in Germany

per Jeske, M, Lohse, P, Kallinich, T, Berger, T, Rietschel, C, Holzinger, D, Kamlah, C, Lankisch, P, Berendes, R, Dückers, G, Horneff, G, Lilienthal, E, Haas, JP, Giese, A, Dressler, F, Berrang, J, Pütter, C, Braunewell, L, Neudorf, U, Niehues, T, Lainka, E
Publicat 2013